Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tagawa

Showing results (311-320 of 419) with videos related to

Pageof 42
Sort By:
Plos One|January 4, 2014
Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowGunjan Gakhar, Vicente N Navarro, Madelyn Jurish, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial CancerMichael Karass, Rohan Bareja, Ethan Shelkey, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomesGiuseppe Galletti, Ahmed Halima, Ada Gjyrezi, et al.
Gene Therapy|April 26, 2002
Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNAT Tagawa, M Manvell, N Brown, et al.
BMC Cancer|August 23, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, et al.
European Urology|September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneityHimisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Molecular Cancer Therapeutics|March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based ChemotherapyVincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Journal of Thrombosis and Haemostasis : JTH|June 2, 2022
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomesBabak B Navi, Cenai Zhang, Carla P Sherman, et al.
Pageof 42

Showing results (311-320 of 419) with videos related to

Sort By:
Pageof 42
Plos One|January 4, 2014
Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowGunjan Gakhar, Vicente N Navarro, Madelyn Jurish, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial CancerMichael Karass, Rohan Bareja, Ethan Shelkey, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomesGiuseppe Galletti, Ahmed Halima, Ada Gjyrezi, et al.
Gene Therapy|April 26, 2002
Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNAT Tagawa, M Manvell, N Brown, et al.
BMC Cancer|August 23, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, et al.
European Urology|September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneityHimisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Molecular Cancer Therapeutics|March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based ChemotherapyVincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Journal of Thrombosis and Haemostasis : JTH|June 2, 2022
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomesBabak B Navi, Cenai Zhang, Carla P Sherman, et al.
Pageof 42